Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
5 ‘Strong Buy' Stocks Under $10 Are Household Names and Could Explode Higher
06:10am, Saturday, 01'st Jul 2023
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Is Novavax Stock A Buy Or A Sell As Shares Stage A Comeback On A Cost-Cutting Plan?
11:54am, Friday, 30'th Jun 2023
Novavax stock is on the rise after announcing a cost-cutting plan and bullish sales guidance. Is NVAX stock a buy or a sell today?
Get Out Now! 3 Stocks to Dump Before the Short-Selling Ban.
05:08pm, Wednesday, 28'th Jun 2023
Selling stocks short is a practice that's once again facing criticism, and a potential ban, following the collapse of multiple regional banks earlier in the year. Short selling is a risky practice whe
3 Pharma Stocks That Have Big Investors Running for the Exit
06:00am, Wednesday, 28'th Jun 2023
Pharmaceutical stocks are trailing the market this year. So far in 2023, the Dow Jones U.S. Select Pharmaceuticals Index is down 5.4% while all three major indices are positive on the year.
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
03:37pm, Thursday, 22'nd Jun 2023
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start
09:07am, Tuesday, 20'th Jun 2023
The FDA's strain selection puts Pfizer, Moderna and Novavax on track to deliver updated coronavirus shots in time for the fall.
What Do Bears Know About Novavax That Bulls Don't?
05:30am, Tuesday, 20'th Jun 2023
Novavax is preparing to launch an updated coronavirus vaccine this fall, along with bigger rivals Pfizer and Moderna. The company also is in the middle of a restructuring effort that involves a potent
FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall
02:14pm, Friday, 16'th Jun 2023
The FDA's decision is a win for vaccine makers Pfizer, Moderna and Novavax, which have all been developing versions of their Covid shots to target XBB.1.5.
FDA Panel Endorses Updating COVID Jab to Target XBB Strain
01:05pm, Friday, 16'th Jun 2023
An FDA panel unanimously recommends updating COVID vaccines to target one of the currently dominating XBB strains of the virus.
Exit Strategy: Get Out of These 3 Poor-Performing Stocks Now
07:00am, Friday, 16'th Jun 2023
Not all stocks are worthy of investor capital. Today, we'll be looking at three poor-performing stocks to avoid.
7 High-Risk, High-Reward Stocks to Buy in June
11:29am, Monday, 12'th Jun 2023
There are some similarities between gambling and buying high-risk, high-reward stocks. In both scenarios, you could make a great deal of money or you could lose all of it.
1 Stock Down 83% That Could Triple, According to Wall Street
08:40am, Friday, 09'th Jun 2023
Novavax's hopes in the coronavirus vaccine market have largely faded. The company has little going on elsewhere.
Why Is Novavax (NVAX) Down 14.7% Since Last Earnings Report?
12:38pm, Thursday, 08'th Jun 2023
Novavax (NVAX) reported earnings 30 days ago. What's next for the stock?
3 Biotech Stocks to Sell in June Before They Crash and Burn
09:11am, Tuesday, 06'th Jun 2023
The biotechnology sector has seen better days. From the heady days of the pandemic when companies were racing to develop a vaccine against Covid-19, the industry is now enduring a hangover as both dem
Novavax exec says its new COVID shot should work against variants on the rise
06:31pm, Monday, 05'th Jun 2023
Novavax Inc's head of research and development on Monday said an updated COVID-19 vaccine the company is already producing is likely to be protective against other fast-growing coronavirus variants ci
